BioStem Technologies, Inc. (BSEM)
3.56
+0.06
(+1.71%)
USD |
NASDAQ |
Sep 02, 16:00
3.56
0.00 (0.00%)
After-Hours: 17:53
BioStem Technologies Research and Development Expense (TTM) : 5.309M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.309M |
| March 31, 2026 | 6.533M |
| December 31, 2025 | 7.086M |
| September 30, 2025 | 6.878M |
| June 30, 2025 | 5.409M |
| March 31, 2025 | 3.537M |
| Date | Value |
|---|---|
| December 31, 2024 | 1.917M |
| September 30, 2024 | 0.9868M |
| June 30, 2024 | 0.5354M |
| March 31, 2024 | 0.5112M |
| December 31, 2023 | 0.4404M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Filana Therapeutics, Inc. | 15.66M |
| CorMedix, Inc. | 27.59M |
| Eloxx Pharmaceuticals, Inc. | 6.647M |
| Cannabis Global, Inc. | -- |
| Breakthrough Chemistry, Inc. | 0.0082M |